Available Technologies by Category
Antigen-specific Cell Programming Using non-viral Approaches
  • This innovative technology uses synthetic nanoparticles to deliver gene modulators and engineered MHC molecules directly to antigen-specific T cells in vivo, enhancing T cell functions and bypassing ex vivo processes.
  • The prototype improves T cell specificity and reduces off-target toxicity, significantly lowering costs and manufacturing time for effective T cell therapies.
  • It has applications in cancer therapy, immune therapy, autoimmune disease therapy, and infectious disease therapy.
Inline manipulation of cells and cell clusters
  • This extracorporeal circulation system enriches CTC clusters from large blood volumes, enabling detailed longitudinal screening and analysis of metastasis.
  • The prototype improves detection rates and facilitates continuous monitoring and in vitro analysis of CTC clusters, aiding early cancer detection and treatment.
  • It supports in-line dialysis systems for pathogenic cells, enhances cancer diagnosis, and provides research tools for studying tumor biology and developing treatments.
Scarless isolation of antigen-specific T cells for CAR T cell manufacturing via DNA-gated sorting
  • This technology introduces DNA-gated sorting (DGS) for label-free isolation of antigen-specific CD8+ T cells, improving CAR T cell therapy.
  • The prototype enhances CAR T cell scalability and therapeutic effectiveness against solid tumors by using a DNA gate mechanism for targeted T cell capture and release.
  • DGS improves in vivo persistence and specificity of CAR T cells, offering better treatment outcomes for solid tumors and other cancers.
Activity-based synthetic liquid biopsy of solid tumors
  • Activatable biosensors injected into tumors capture dynamic biological activity and immune responses, allowing non-invasive monitoring of tumor responses through bodily fluids.
  • The prototype offers real-time insights into tumor behavior and treatment effectiveness, providing a less invasive alternative to traditional biopsies.
  • This method enhances sensitivity and specificity for tumor-specific biomarkers, improving monitoring of drug responses and cancer progression.
Needle-like Nanostructures to Deliver Multi-scale Biomolecules to Non-activated Immune Cells
  • This functionalized nanowire platform delivers multiple genetic materials to naïve T and B cells without pre-activation, enhancing their efficacy in adoptive cell therapy.
  • The prototype improves gene delivery efficiency while preserving the naïve state of immune cells, increasing cell viability and immune response modulation.
  • It offers superior protection against intracellular pathogens and serves as a research tool for immune cell manipulation across various species, ages, and subtypes.
Multi-Niche Human Bone Marrow-On-A-Chip for Plasma Cell Survival and Differentiation
  • This novel microfluidic chip simulates the human bone marrow environment, incorporating multiple niches and supporting long-term plasma cell culture and study.
  • The prototype enables comprehensive study of plasma cell maturation, aiding the development of targeted therapies for plasma cell-related disorders.
  • It overcomes limitations in traditional plasma cell culture, facilitating vaccine development, antibody production research, and immune response modulation.
Lymphoid-Lymphatics-Integrated Organ-on-Chip Device and Method
  • This innovative organ-on-chip system combines vascularized lung and lymphoid tissues, aiding studies on airway infections.
  • The prototype supports diverse cell cultures, making it useful for screening treatments and vaccines.
  • It enhances current lung-on-chip models by accurately simulating lung tissue and immune responses.
A Multi-Stage Cascade Air Conditioning and Refrigeration System Using Thermally Responsive Liquids
  • Innovative technology using thermally responsive liquids in multiple stages enhances air conditioning and refrigeration systems.
  • Currently at proof-of-concept stage, it aims to improve temperature and humidity control efficiency.
  • Offers eco-friendly cooling and dehumidification with zero global warming potential, targeting residential, commercial, and data center applications.
T cell Secretion of Engineered Enzymatic Weapons for Solid Tumor Translation
  • This innovation involves genetically modifying human cells to secrete an enzyme that breaks down adenosine, enhancing CAR-T and other T cell therapies' effectiveness against solid tumors.
  • The prototype addresses adenosine-mediated immunosuppression, improving therapy specificity and efficacy in treating solid tumors.
  • It has commercial applications in enhancing CAR-T cell therapies and other immunotherapy treatments for various cancers, marking a significant advancement in cancer care.
Methods and Markers for Ovarian Cancer Diagnosis and Stratification
  • This technology utilizes advanced machine learning algorithms and lipid panels to distinguish high-grade serous ovarian cancer from other reproductive system cancers, enhancing diagnostic accuracy and early detection capabilities.
  • The prototype improves treatment decision-making and patient monitoring, particularly for individuals with genetic predispositions to ovarian cancer.
  • It serves as a diagnostic tool for ovarian cancer detection, either standalone or alongside existing tests like CA125 and HE4, offering precise diagnosis and aiding in treatment planning.
An Electronic Microfluidic Platform for On-Chip Apoptosis Quantification using Annexin V-Based PS Externalization Detection-GT NEXT
  • This electronic microchip integrates an electrical sensor network with a microfluidic capture chamber to detect phosphatidylserine (PS) externalization, offering a compact, user-friendly, and cost-effective solution for apoptotic analysis.
  • The prototype provides high sensitivity and specificity without the need for prelabeling, making it suitable for diverse applications in clinical diagnostics and biomedical research.
  • It supports drug discovery, toxicity evaluation, and bioprocessing optimizations, enhancing disease mechanism studies and therapeutic target identification.
Capillary Driven Microneedle Patch for Blood Biomarker Analysis
  • This bioresorbable thermoplastic microneedle platform accurately collects capillary blood and quantifies biomarkers on-chip, supported by a smartphone attachment for easy read-out.
  • The prototype integrates hollow microneedles with microfluidic patterns and crossflow filtration, providing low-cost, reliable, and sensitive point-of-care blood testing.
  • It enables point-of-care personalized diagnostics and blood biomarker analysis in clinical and remote settings without expensive peripheral equipment.
BiCMOS Process Integrated Silicon-Germanium Avalanche Photodiode
  • The invention introduces a novel semiconductor photodetector design, leveraging the principle of avalanche multiplication to detect light signals effectively.
  • It enables cost-effective high-volume production through the utilization of existing semiconductor foundry processes, bypassing traditional constraints.
  • This innovative design supports the integration of a complete optical receiver subsystem onto a single chip, thereby enhancing performance and streamlining production processes.
Functionalized Nanowires for miRNA-mediated Programming of Naive T Cells
  • Technology Overview: Georgia Tech's functionalized nanowires deliver genetic materials like miRNAs and CRISPR directly to naive T cells, enhancing their therapeutic potential without pre-activation.
  • Advantages: This method preserves the naive state of T cells, allowing for better viability and functionality, reduced exhaustion, and delivery of both small and large biomolecules, including lentiviral particles.
  • Commercial Applications: The technology can be used in adoptive T cell therapy for cancer and infectious diseases, therapeutic delivery of biomolecules, and as a research tool for immune cell manipulation.
Lymphoid Tissues with Switchable Protein Gradients
  • Technology Overview: Georgia Tech's hydrogel-based immune organoids mimic lymphoid tissue, enabling ex vivo differentiation of B cells and studying immune responses to infections and vaccinations.
  • Advantages: This non-invasive method supports long-term B and T cell survival, mimics antibody production processes, and offers insights into diseases like lymphoma.
  • Commercial Applications: Useful for drug discovery, clinical research on immune disorders, personalized medicine, and academic studies in immunology.
Engineering Antigen-Specific T Cells for CAR T Cell Therapy via Antigen-Presenting Lipid Nanoparticles
  • Technology Overview: Georgia Tech's new CAR T cell therapy uses lipid nanoparticles (LNPs) to program antigen-specific T cells in vivo, potentially reducing costs and production time.

  • Advantages: This approach avoids expensive and time-consuming ex vivo manufacturing, minimizes off-target effects, can adapt to various CAR constructs and cancer types, and promises rapid scaling and reduced costs.

  • Commercial Applications: Applicable to multiple myeloma, CD19+ cancers, and a wide range of other cancers, this technology streamlines CAR T cell therapy manufacturing for faster, more affordable treatments.

Driving Neural Activity to Rapidly Control Inflammation, Protein, and Gene Expression in the Brain
  • Novel non-invasive method utilizing neural activity to swiftly control inflammation, protein, and gene expression in the brain.
  • The technology enables rapid and precise modulation of brain functions, potentially revolutionizing treatment for various neurological conditions.
  • Commercial applications include treating Alzheimer's, schizophrenia, autism, epilepsy, and more, offering faster, non-invasive, and targeted therapeutic options.
Lipid Nanoparticle-Mediated Delivery of mRNA Encoded Synthetic Antigens for CAR T Cell Therapy
  • Georgia Tech's novel CAR T cell therapy uses lipid nanoparticles (LNPs) to deliver mRNA-encoded synthetic antigens, improving targeting of solid tumors and reducing off-target effects.

  • The technology ensures efficient mRNA delivery, prompting tumor cells to express unique antigens, enhancing immune recognition and destruction of cancer cells.

  • This approach broadens CAR T cell therapy applicability, allows repeat dosing, and minimizes off-tumor toxicity, offering significant advantages over traditional methods.

Organic Molecules with Delayed Fluorescence for Human-Centric Lighting and Radiation Detectors
  • Innovative light converter tech mimics natural daylight using organic molecules with delayed fluorescence, surpassing current solutions.
  • The technology addresses health issues caused by artificial lighting, offering stable, energy-efficient human-centric lighting.
  • It has versatile applications include indoor lighting, therapy for mood disorders, and smart lighting systems.
Controlling the Solubility and Electrical Conductivity of Organic Semiconductor Films by Reversible Doping
  • This innovation introduces a novel approach for achieving precise p-type doping and reversible solubility control in organic semiconductor layers, thereby enhancing their conductivity and stability.
  • It provides solution processability and minimal dopant diffusion, leading to improved performance and versatility for a wide range of electronic devices.
  • This technology finds applications in printed electronics, organic solar cells, LEDs, transistors, and sensors, facilitating the production of thin, flexible components with enduring performance.